Cytotoxic agents comprising new taxanes

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Reexamination Certificate

active

07667054

ABSTRACT:
The invention relates to novel cytotoxic agents comprising taxanes and their therapeutic use as a result of delivering the taxanes to a specific cell population in a targeted fashion by chemically linking the taxane to a cell binding agent.

REFERENCES:
patent: 5728849 (1998-03-01), Bouchard et al.
patent: 6340701 (2002-01-01), Chari et al.
patent: 6372738 (2002-04-01), Chari et al.
patent: 6436931 (2002-08-01), Chari et al.
patent: 0 617 034 (1994-09-01), None
patent: WO97/23473 (1997-07-01), None
patent: WO 01/38318 (2001-05-01), None
patent: WO 03/097625 (2003-11-01), None
patent: WO 2004/013093 (2004-02-01), None
Miller et al, Synthesis of Potent Taxoids for Tumor-specific Delivery Using Monoclonal Antibodies, Bioorganic & Medicinal Chemistry Letters 14 (2004) 4079-4082.
Miller et al, Synthesis of Taxoids with Improved Cytotoxicity and Solubility for Use in Tumor-Specific Delivery, J. Med. Chem, 2004, 47, 4802-4805.
Ojima et al, Tumor-Specific Novel Taxoid-Monoclonal Antibody Conjugates, J. Med. Chem. 2002, 45, 5620-5623.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Cytotoxic agents comprising new taxanes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cytotoxic agents comprising new taxanes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytotoxic agents comprising new taxanes will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4194510

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.